BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...from Harvard Medical School, Taizhou University and Zhejiang University School of Medicine...
...Calgary Rutgers University Queen Mary University of London Harvard Medical School Zhejiang University School of Medicine University...
BioCentury | Dec 2, 2020
Distillery Therapeutics

Apoptosis regulator MCL1 as an Alzheimer’s target

...Chinaemail: jie_wu@fudan.edu.cnCONTACT: Ayaz Najafov, Harvard Medical School, Boston, Mass.email: ayaz_najafov@hms.harvard.eduCONTACT: Hongguang Xia, Zhejiang University School of Medicine, Hangzhou, Chinaemail: hongguangxia@zju.edu.cn Claire Quang Harvard Medical School Zhejiang University School of Medicine Myeloid...
BioCentury | Apr 1, 2020
Distillery Therapeutics

Base editor correction of TERT promoter mutations for glioma

...Beijing, China email: lixinjian@ibp.ac.cn CONTACT: Zhimin Lu, Zhejiang University School of Medicine, Hangzhou, China email: zhiminlu@zju.edu.cn Claire Quang Chinese Academy of Sciences Zhejiang University School of Medicine Telomerase...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...molecular regulators of immune polarization using gene knockouts, mutations or tool compounds. A presentation from Zhejiang University School of Medicine...
...TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical University of South Carolina Zhejiang University School of Medicine V-region...
BioCentury | May 8, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: April 2019

...sample and mouse studies suggest miR-19a and miR-19b or their mimics could help treat MI Zhejiang University School of Medicine...
BioCentury | Apr 30, 2019
Distillery Therapeutics

miR-19a and miR-19b and their mimics for myocardial infarction

...Zhejiang University School of Medicine, Hangzhou, China email: jinghaichen@zju.edu.cn CONTACT: Da-Zhi Wang, Harvard University, Cambridge, Mass. email: da-zhi.wang@childrens.harvard.edu Claire Quang Harvard University Zhejiang University School of Medicine MicroRNA-19a...
BioCentury | Mar 25, 2019
Distillery Therapeutics

Inhibiting EFR3A to treat Alzheimer's disease

...doi:10.1038/s41467-019-09114-z CONTACT: Fu-De Huang, Chinese Academy of Sciences, Shanghai, China email: huangfd@sari.ac.cn CONTACT: Yi Shen, Zhejiang University School of Medicine...
...China email: yshen2@zju.edu.cn CONTACT: Yu-Dong Zhou, same affiliation as above email: yudongzhou@zju.edu.cn Claire Quang Chinese Academy of Sciences Zhejiang University School of Medicine EFR3...
BioCentury | Feb 28, 2019
Distillery Therapeutics

Cancer

...Zhang, F. et al. Immunity ; published online Feb. 12, 2019 doi:10.1016/j.immuni.2019.01.010 CONTACT: Jianli Wang, Zhejiang University School of Medicine...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Neurology

...published online Jan. 14, 2019 doi:10.1038/s41591-018-0299-9 CONTACT: Xiao-Ming Li, Zhejiang University School of Medicine, Hangzhou, China email: lixm@zju.edu.cn Claire Quang Zhejiang University School of Medicine Cannabinoid...
BioCentury | Jan 3, 2019
Distillery Therapeutics

Autoimmune disease

...Nanjing University, Nanjing, China email: gaoxiang@nju.edu.cn CONTACT: Linrong Lu, Zhejiang University School of Medicine, Hangzhou, China email: lu_linrong@zju.edu.cn Claire Quang Nanjing University Zhejiang University School of Medicine Protein...
Items per page:
1 - 10 of 19
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...from Harvard Medical School, Taizhou University and Zhejiang University School of Medicine...
...Calgary Rutgers University Queen Mary University of London Harvard Medical School Zhejiang University School of Medicine University...
BioCentury | Dec 2, 2020
Distillery Therapeutics

Apoptosis regulator MCL1 as an Alzheimer’s target

...Chinaemail: jie_wu@fudan.edu.cnCONTACT: Ayaz Najafov, Harvard Medical School, Boston, Mass.email: ayaz_najafov@hms.harvard.eduCONTACT: Hongguang Xia, Zhejiang University School of Medicine, Hangzhou, Chinaemail: hongguangxia@zju.edu.cn Claire Quang Harvard Medical School Zhejiang University School of Medicine Myeloid...
BioCentury | Apr 1, 2020
Distillery Therapeutics

Base editor correction of TERT promoter mutations for glioma

...Beijing, China email: lixinjian@ibp.ac.cn CONTACT: Zhimin Lu, Zhejiang University School of Medicine, Hangzhou, China email: zhiminlu@zju.edu.cn Claire Quang Chinese Academy of Sciences Zhejiang University School of Medicine Telomerase...
BioCentury | Dec 6, 2019
Targets & Mechanisms

A view of immune reprogramming from ASH

...molecular regulators of immune polarization using gene knockouts, mutations or tool compounds. A presentation from Zhejiang University School of Medicine...
...TAK-924) American Society of Hematology Takeda Pharmaceutical Co. Ltd. Fudan University National Institutes of Health Dartmouth College Medical University of South Carolina Zhejiang University School of Medicine V-region...
BioCentury | May 8, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: April 2019

...sample and mouse studies suggest miR-19a and miR-19b or their mimics could help treat MI Zhejiang University School of Medicine...
BioCentury | Apr 30, 2019
Distillery Therapeutics

miR-19a and miR-19b and their mimics for myocardial infarction

...Zhejiang University School of Medicine, Hangzhou, China email: jinghaichen@zju.edu.cn CONTACT: Da-Zhi Wang, Harvard University, Cambridge, Mass. email: da-zhi.wang@childrens.harvard.edu Claire Quang Harvard University Zhejiang University School of Medicine MicroRNA-19a...
BioCentury | Mar 25, 2019
Distillery Therapeutics

Inhibiting EFR3A to treat Alzheimer's disease

...doi:10.1038/s41467-019-09114-z CONTACT: Fu-De Huang, Chinese Academy of Sciences, Shanghai, China email: huangfd@sari.ac.cn CONTACT: Yi Shen, Zhejiang University School of Medicine...
...China email: yshen2@zju.edu.cn CONTACT: Yu-Dong Zhou, same affiliation as above email: yudongzhou@zju.edu.cn Claire Quang Chinese Academy of Sciences Zhejiang University School of Medicine EFR3...
BioCentury | Feb 28, 2019
Distillery Therapeutics

Cancer

...Zhang, F. et al. Immunity ; published online Feb. 12, 2019 doi:10.1016/j.immuni.2019.01.010 CONTACT: Jianli Wang, Zhejiang University School of Medicine...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Neurology

...published online Jan. 14, 2019 doi:10.1038/s41591-018-0299-9 CONTACT: Xiao-Ming Li, Zhejiang University School of Medicine, Hangzhou, China email: lixm@zju.edu.cn Claire Quang Zhejiang University School of Medicine Cannabinoid...
BioCentury | Jan 3, 2019
Distillery Therapeutics

Autoimmune disease

...Nanjing University, Nanjing, China email: gaoxiang@nju.edu.cn CONTACT: Linrong Lu, Zhejiang University School of Medicine, Hangzhou, China email: lu_linrong@zju.edu.cn Claire Quang Nanjing University Zhejiang University School of Medicine Protein...
Items per page:
1 - 10 of 19